Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.
Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.
Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.